Paradromics, a Neuralink competitor, has successfully completed its first human brain implant, marking a significant breakthrough in brain-computer interface technology.

Neuralink rival Paradromics has implanted its Connexus brain chip in a woman who lost her speech to motor neuron disease, the first patient in its FDA study.

Paradromics CEO Matt Angle said the patient will start testing the device in the coming weeks with the goal of restoring her ability to communicate.

Paradromics ha impiantato per la prima volta il proprio chip cerebrale Connexus in una paziente affetta da malattia del motoneurone. Lo studio clinico approvato dalla FDA mira a…

Paradromics, a Neuralink competitor, has successfully completed its first human brain implant, marking a significant breakthrough in brain-computer interface technology.

The number of people with electrodes in their brains is believed to have more than doubled in the last couple of years.